ERBB2 and cancer: The cytotoxic effect of our conjugate on HER2-positive cancer cells was confirmed in in vitro cytotoxicity assays, demonstrating that this cytotoxic conjugate, upon further in vivo evaluation, can serve as a potential anticancer agent.